Renal cancer response to rapamycin analog CCI-779 treatment: time course - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS3603

Renal cancer response to rapamycin analog CCI-779 treatment: time course

Expression profiling of peripheral blood mononuclear cells (PBMC) from patients with advanced renal cancer following treatment with the rapamycin analog CCI-779. Gene expression examined 8 and 16 weeks after treatment. Results identify potential gene markers of CCI-779 exposure.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 3 time sets

Platform:: GPL8300
Series:: GSE1982
79 Samples

DataSet

Accession:: GDS3603

ID:: 3603

PubMed Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Renal cancer response to rapamycin analog CCI-779 treatment: time course
Renal cancer response to rapamycin analog CCI-779 treatment: time course
Accession: GDS3603

GEO DataSets
Related DataSets for GEO Profiles (Select 62089709) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets